Virology-the path forward.

Humans Containment of Biohazards COVID-19 United States Viruses Virology Biomedical Research / standards
COVID-19 SARS-CoV-2 biosafety emergence oversight virology

Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
23 Jan 2024
Historique:
medline: 24 1 2024
pubmed: 4 1 2024
entrez: 3 1 2024
Statut: ppublish

Résumé

In the United States (US), biosafety and biosecurity oversight of research on viruses is being reappraised. Safety in virology research is paramount and oversight frameworks should be reviewed periodically. Changes should be made with care, however, to avoid impeding science that is essential for rapidly reducing and responding to pandemic threats as well as addressing more common challenges caused by infectious diseases. Decades of research uniquely positioned the US to be able to respond to the COVID-19 crisis with astounding speed, delivering life-saving vaccines within a year of identifying the virus. We should embolden and empower this strength, which is a vital part of protecting the health, economy, and security of US citizens. Herein, we offer our perspectives on priorities for revised rules governing virology research in the US.

Identifiants

DOI: 10.1128/jvi.01791-23 PMID: 38168672 PMC: PMC10804978
pubmed: 38168672
doi: 10.1128/jvi.01791-23
pmc: PMC10804978
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0179123

Commentaires et corrections

Type : ErratumIn

Références

Euro Surveill. 2023 Aug;28(31):
pubmed: 37535475
Nature. 2023 Apr 5;:
pubmed: 37019149
J Virol. 2023 Feb 28;97(2):e0008923
pubmed: 36700640
Science. 2022 Aug 26;377(6609):951-959
pubmed: 35881010
Nature. 2012 May 02;486(7403):420-8
pubmed: 22722205
Science. 2012 Jun 22;336(6088):1534-41
pubmed: 22723413
Euro Surveill. 2023 Jan;28(3):
pubmed: 36695488
Nat Commun. 2023 Sep 7;14(1):5489
pubmed: 37679333
Nature. 2008 Sep 18;455(7211):290-1
pubmed: 18800118
mBio. 2020 May 29;11(3):
pubmed: 32471830
J Virol. 2001 Sep;75(18):8353-5
pubmed: 11507180
J Virol. 2001 Feb;75(3):1205-10
pubmed: 11152493
Science. 2022 Aug 26;377(6609):960-966
pubmed: 35881005
Am J Public Health. 2013 Aug;103(8):1393-401
pubmed: 23763422

Auteurs

Angela L Rasmussen (AL)

Vaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, Canada.
Department of Biochemistry, Microbiology, and Immunology, University of Saskatchewan, Saskatoon, Canada.
Department of Ecology and Evolution, Stony Brook University, Stony Brook, New York, USA.
ORCID: 0000-0001-9462-3169

Gigi K Gronvall (GK)

Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
ORCID: 0000-0003-2514-146X

Anice C Lowen (AC)

Department of Microbiology and Immunology, Emory University, Atlanta, Georgia, USA.
ORCID: 0000-0002-9829-112X

Felicia Goodrum (F)

Department of Immunobiology, University of Arizona, Tucson, Arizona, USA.
ORCID: 0000-0002-6646-7290

James Alwine (J)

Department of Cancer Biology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Kristian G Andersen (KG)

Department of Immunology and Microbiology, Scripps Research, La Jolla, California, USA.

Simon J Anthony (SJ)

Department of Pathology, Microbiology, and Immunology, University of California, Davis, Davis, California, USA.

Joel Baines (J)

Department of Microbiology and Immunology, Cornell University, Ithaca, New York, USA.
ORCID: 0000-0002-6397-2830

Arinjay Banerjee (A)

Vaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, Canada.
ORCID: 0000-0002-2821-8357

Andrew J Broadbent (AJ)

Department of Animal and Avian Sciences, University of Maryland, College Park, Maryland, USA.
ORCID: 0000-0002-4716-1835

Christopher B Brooke (CB)

Department of Microbiology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
ORCID: 0000-0002-6815-1193

Samuel K Campos (SK)

Department of Immunobiology, University of Arizona, Tucson, Arizona, USA.
ORCID: 0000-0003-1540-9821

Patrizia Caposio (P)

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.
ORCID: 0000-0001-7579-849X

Arturo Casadevall (A)

Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
ORCID: 0000-0002-9402-9167

Gary C Chan (GC)

Department of Microbiology and Immunology, SUNY Upstate Medical Center, Syracuse, New York, USA.
ORCID: 0000-0001-8209-9777

Anna R Cliffe (AR)

Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia, USA.
ORCID: 0000-0003-1136-5171

Donna Collins-McMillen (D)

Department of Immunobiology, University of Arizona, Tucson, Arizona, USA.

Nancy Connell (N)

Department of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA.

Blossom Damania (B)

Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
ORCID: 0000-0002-9205-1774

Matthew D Daugherty (MD)

Department of Molecular Biology, University of California, San Diego, La Jolla, California, USA.

Kari Debbink (K)

Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Terence S Dermody (TS)

Department of Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
ORCID: 0000-0003-1853-8741

Daniel DiMaio (D)

Department of Genetics, Yale School of Medicine, New Haven, Connecticut, USA.
ORCID: 0000-0002-2060-5977

W Paul Duprex (WP)

Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
ORCID: 0000-0003-1716-6376

Michael Emerman (M)

Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

Denise A Galloway (DA)

Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

Robert F Garry (RF)

Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, Louisiana, USA.

Stephen A Goldstein (SA)

Department of Human Genetics, University of Utah School of Medicine, Salt Lake City, Utah, USA.

Alexander L Greninger (AL)

Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
ORCID: 0000-0002-7443-0527

Amy L Hartman (AL)

Department of Infectious Diseases and Microbiology, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania, USA.
ORCID: 0000-0002-0857-2973

Brenda G Hogue (BG)

School of Life Sciences, Arizona State University, Tempe, Arizona, USA.

Stacy M Horner (SM)

Department of Integrative Immunobiology, Duke University School of Medicine, Durham, North Carolina, USA.
ORCID: 0000-0002-9351-7409

Peter J Hotez (PJ)

Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, USA.
Department of Molecular Virology and Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, USA.

Jae U Jung (JU)

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
ORCID: 0000-0003-4559-8774

Jeremy P Kamil (JP)

Department of Microbiology and Immunology, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA.
ORCID: 0000-0001-8422-7656

Stephanie M Karst (SM)

Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, USA.

Lou Laimins (L)

Department of Microbiology, Ohio State University, Wooster, Ohio, USA.
ORCID: 0000-0002-6314-623X

Seema S Lakdawala (SS)

Department of Microbiology and Immunology, Emory University, Atlanta, Georgia, USA.
ORCID: 0000-0002-7679-2150

Igor Landais (I)

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.

Michael Letko (M)

Paul G. Allen School for Global Health, Washington State University, Pullman, Washington, USA.
ORCID: 0000-0002-7640-2861

Brett Lindenbach (B)

Department of Microbial Pathogenesis, Yale University, New Haven, USA.

Shan-Lu Liu (S-L)

Department of Microbiology, Ohio State University, Wooster, Ohio, USA.
Viruses and Emerging Pathogens Program, Infectious Diseases Institute, Ohio State University, Wooster, Ohio, USA.
ORCID: 0000-0003-1620-3817

Micah Luftig (M)

Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, North Carolina, USA.
ORCID: 0000-0002-2964-1907

Grant McFadden (G)

School of Life Sciences, Arizona State University, Tempe, Arizona, USA.
ORCID: 0000-0002-2556-3526

Andrew Mehle (A)

Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
ORCID: 0000-0001-6060-4330

Juliet Morrison (J)

Department of Microbiology and Plant Pathology, University of California, Riverside, Riverside, California, USA.

Anne Moscona (A)

Department of Microbiology and Immunology, Columbia University, New York, New York, USA.
Department of Physiology, Columbia University, New York, New York, USA.
Department of Biophysics, Columbia University, New York, New York, USA.
ORCID: 0000-0002-1796-8320

Elke Mühlberger (E)

Department of Virology, Immunology, and Microbiology, Boston University, Boston, Massachusetts, USA.

Joshua Munger (J)

Department of Biochemistry and Biophysics, University of Rochester, Rochester, New York, USA.
ORCID: 0000-0001-5379-9440

Karl Münger (K)

Department of Developmental, Molecular, and Chemical Biology, Tufts University School of Medicine, Boston, Massachusetts, USA.

Eain Murphy (E)

Department of Microbiology and Immunology, SUNY Upstate Medical Center, Syracuse, New York, USA.
ORCID: 0000-0003-3449-5024

Christopher J Neufeldt (CJ)

Department of Microbiology and Immunology, Emory University, Atlanta, Georgia, USA.

Janko Z Nikolich (JZ)

Department of Immunobiology, University of Arizona, Tucson, Arizona, USA.
Aegis Consortium for a Pandemic-Free Future, University of Arizona, Tucson, Arizona, USA.

Christine M O'Connor (CM)

Department of Infection Biology, Cleveland Clinic, Cleveland, Ohio, USA.
ORCID: 0000-0003-4943-3774

Andrew Pekosz (A)

Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
ORCID: 0000-0003-3248-1761

Sallie R Permar (SR)

Department of Pediatrics, Weill Cornell Medicine, New York, New York, USA.
ORCID: 0000-0003-1438-4554

Julie K Pfeiffer (JK)

Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
ORCID: 0000-0003-2973-4895

Saskia V Popescu (SV)

Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.

John G Purdy (JG)

Department of Immunobiology, University of Arizona, Tucson, Arizona, USA.
ORCID: 0000-0001-7460-7567

Vincent R Racaniello (VR)

Department of Microbiology and Immunology, Columbia University, New York, New York, USA.

Charles M Rice (CM)

Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, USA.

Jonathan A Runstadler (JA)

Department of Infectious Disease and Global Health, Cummings School of Veterinary Medicine at Tufts University, North Grafton, Massachusetts, USA.
ORCID: 0000-0002-6747-7765

Martin J Sapp (MJ)

Department of Microbiology and Immunology, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA.
ORCID: 0000-0003-3916-8890

Rona S Scott (RS)

Department of Microbiology and Immunology, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA.
ORCID: 0000-0003-3840-9189

Gregory A Smith (GA)

Department of Microbiology, Ohio State University, Wooster, Ohio, USA.
ORCID: 0000-0001-9644-8472

Erin M Sorrell (EM)

Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Emily Speranza (E)

Florida Research and Innovation Center, Cleveland Clinic Lerner Research Institute, Port St. Lucie, Florida, USA.

Daniel Streblow (D)

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.

Scott A Tibbetts (SA)

Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, USA.
ORCID: 0000-0001-8889-1642

Zsolt Toth (Z)

Department of Oral Biology, University of Florida, Gainesville, Florida, USA.
ORCID: 0000-0001-6628-3945

Koenraad Van Doorslaer (K)

Department of Immunobiology, University of Arizona, Tucson, Arizona, USA.

Susan R Weiss (SR)

Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID: 0000-0002-8155-4528

Elizabeth A White (EA)

Department of Otorhinolaryngology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID: 0000-0001-7378-7690

Timothy M White (TM)

Department of Immunobiology, University of Arizona, Tucson, Arizona, USA.

Christiane E Wobus (CE)

Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.
ORCID: 0000-0001-5286-0924

Michael Worobey (M)

Department of Ecology and Evolutionary Biology, University of Arizona, Tucson, Arizona, USA.

Satoko Yamaoka (S)

Department of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, USA.

Andrew Yurochko (A)

Department of Microbiology and Immunology, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA.
ORCID: 0000-0002-6452-5813

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Virology-the path forward.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Accidents › Prévention des accidents › Sécurité › Confinement de risques biologiques › Virology-the path forward.
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › Virology-the path forward.
questionsmedicales.fr › Régions géographiques › Amériques › Amérique du Nord › États-Unis › Virology-the path forward.
questionsmedicales.fr › Virus › Virology-the path forward.
questionsmedicales.fr › Disciplines des sciences naturelles › Disciplines des sciences biologiques › Biologie › Microbiologie › Virologie › Virology-the path forward.
questionsmedicales.fr › Disciplines des sciences naturelles › Science › Recherche › Recherche biomédicale › Virology-the path forward.